Testing effectiveness (Phase 2)UnknownNCT04371939
What this trial is testing
Efficacy and Safety of Romiplostim Versus Eltrombopag in the Treatment of Thrombocytopenia in Patients With Wiskott-Aldrich Syndrome
Who this might be right for
Wiskott-Aldrich Syndrome
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 30